LeeCChangMD

Anesthesiology • Houston, TX

Assistant Professor, Anesthesiology, Baylor College of Medicine

Join to view full profile

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chang's full profile

Already have an account?

Office
1504 Taub Loop
Houston, TX 77030
Phone+1 713-798-7356

Education & Training

University at BuffaloResidency, Anesthesiology, 2003 - 2007
University at BuffaloInternship, Internal Medicine, 2003 - 2004
University of Texas Southwestern Medical SchoolClass of 2003

Certifications & Licensure

TX State Medical License 2007 - 2025
American Board of Anesthesiology Anesthesiology

Clinical Trials

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension Start of enrollment: 2012 Jan 01
Withdrawn
Early Phase 1
Study Examining Parker-Flex Endotracheal Tube for Obese Patients Start of enrollment: 2013 Jul 01
Completed
Not Applicable

Publications & Presentations

PubMed

1 citations
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
Manish Kumar Jha, Samuel T Wilkinson, Kamini Krishnan, Katherine A Collins, Gerard Sanacora
JAMA Network Open. 2024-06-03
17 citations
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
Marijn Lijffijt, Nicholas Murphy, Sidra Iqbal, Charles Green, Tabish Iqbal
Neuropsychopharmacology. 2021-11-27
146 citations
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Maurizio Fava, Marlene P Freeman, Martina Flynn, Heidi Judge, Bettina B Hoeppner
Molecular Psychiatry. 2020-07-01

Journal Articles

Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)
Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature

Press Mentions

Researchers Discover Positive Effects of Intravenous Ketamine for Treatment-Resistant DepressionMay 25th, 2023